MMJ International Follows FDA Guidance in Marijuana Medicine Development As FDA – Health News Today

MMJ International Holdings achieving multiple milestones in the development of its marijuana THC (tetrahydrocannabinol), CBD (cannabidiol) pharmaceutical continues to follow the FDA guidance in the development of its gel cap medicine.” data-reactid=”12″ST. PETERSBURG, FL / ACCESSWIRE / July 22, 2020 / MMJ International Holdings achieving multiple milestones in the development of its marijuana THC (tetrahydrocannabinol), CBD (cannabidiol) pharmaceutical continues to follow the FDA guidance in the development of its gel cap medicine.

Most recently MMJ International Holdings had received a DEA permit to import its cannabis proprietary extracts into the United States for use as potential therapies in Huntington’s Disease and Multiple Sclerosis.

Two of MMJ’s lead therapeutic candidates, MMJ-001 and MMJ-002, are liquid formulations containing highly purified THC, CBD and other active ingredients. MMJ-001 is being developed to treat spasticity (abnormal muscle stiffness) in people with multiple sclerosis. MMJ-002 is being developed to treat Huntington’s-associated chorea (involuntary jerking or writhing movements).The U.S. Food and Drug Administration (FDA) granted MMJ-002 orphan drug designation in early 2019, to advance the therapy’s development.

separate itself from the pack as the Food and Drug Administration (FDA) is publicizing a voluntary recall of dozens of human CBD products after the Florida Department of Health notified a company of lead contamination.” data-reactid=”31″MMJ International Holdings continues to separate itself from the pack as the Food and Drug Administration (FDA) is publicizing a voluntary recall of dozens of human CBD products after the Florida Department of Health notified a company of lead contamination.

The FDA encouraged consumers to dispose of the products, monitor their health and contact a physician or veterinarian if adverse symptoms are experienced.

“Exposure to lead could present physical signs and symptoms including, pain, paresthesia/muscle weakness, abdominal pain, nausea, vomiting, diarrhea, constipation, poor appetite, weight loss, symptoms associated with encephalitis, metallic taste in the mouth, shock, hemolysis or kidney damage,” FDA said in a notice published last week.

Multiple brands of pet hemp oil products recalled for lead contamination. Certain lots of Tasty Drops, Purfurred, Made by Hemp, Herbal Renewals, Barkley Bistro, A Clean Choice, BC Hemp, Boost IV Hydration, Acadia Farms. Stop using these lots immediately.

9:57 AM · Jul 18, 2020” data-reactid=”35″9:57 AM · Jul 18, 2020

The FDA currently does not allow for CBD to be marketed as a medicine, food item or dietary supplement without its approval.

FDA published draft guidance on marijuana and CBD research the recently cleared a White House Office of Management and Budget review which MMJ International Holdings has been following in its development process of it medicine.” data-reactid=”37″On Tuesday,

LEAVE A REPLY

Please enter your comment!
Please enter your name here